Mark A Stein Selected Research

Dexmethylphenidate Hydrochloride

6/2014	Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.
12/2011	Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.
8/2007	The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Stein Research Topics

Disease

45	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2022 - 04/2003
1	Sluggish Cognitive Tempo 03/2018
1	Autism Spectrum Disorder 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Brain Diseases (Brain Disorder) 12/2009
1	Schizophrenia (Dementia Praecox) 12/2009
1	Alzheimer Disease (Alzheimer's Disease) 12/2009
1	Substance-Related Disorders (Drug Abuse) 08/2007
1	Mood Disorders (Mood Disorder) 04/2003
1	Mental Disorders (Mental Disorder) 04/2003

Drug/Important Bio-Agent (IBA)

17	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 11/2003
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2015
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2014 - 07/2005
4	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 07/2017 - 08/2007
3	Pharmaceutical PreparationsIBA 01/2019 - 02/2010
3	Amphetamine (Amfetamine)FDA LinkGeneric 01/2019 - 12/2011
3	Dexmethylphenidate Hydrochloride FDA LinkGeneric 06/2014 - 08/2007
2	gamma-Aminobutyric Acid (GABA)IBA 04/2022 - 01/2021
2	Dopamine Agents (Dopaminergic Agents)IBA 07/2017 - 01/2007
2	Guanfacine (Tenex)FDA LinkGeneric 11/2015 - 09/2013
2	SaltsIBA 06/2014 - 12/2011
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2010 - 02/2010
2	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2010 - 09/2007
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 02/2010 - 12/2009
2	CatecholaminesIBA 12/2009 - 04/2008
1	Glutamic Acid (Glutamate)FDA Link 04/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Lisdexamfetamine Dimesylate FDA Link 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2015
1	tyramine-deoxysorbitolIBA 01/2015
1	TEMPOIBA 09/2013
1	Synaptosomal-Associated Protein 25IBA 02/2010
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 02/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2010
1	Dopamine (Intropin)FDA LinkGeneric 02/2010
1	EnzymesIBA 02/2010
1	Cholinergic AgonistsIBA 12/2009
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	Cholinergic Agents (Cholinergics)IBA 12/2009
1	choline transporterIBA 12/2009
1	Controlled SubstancesIBA 08/2007
1	Homovanillic AcidIBA 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	Thyroid HormonesIBA 04/2003
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2003

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2008
3	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
2	Precision Medicine 01/2022 - 01/2021
1	Medical Day Care (Partial Hospitalization) 12/2022
1	Treatment Delay 01/2021
1	Duration of Therapy 01/2020
1	Aftercare (After-Treatment) 01/2019